Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern

Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is the most common inflammatory demyelinating disease in children, yet few studies have examined health-related quality of life (HRQOL) in this population. This study aimed to compare HRQOL between children with MOGAD and healthy controls, and to identify risk factors for impaired HRQOL. Methods In this retrospective, single-center case-control study, children with MOGAD (147 patients) and healthy controls (150 subjects) were enrolled. HRQOL was assessed using the PedsQL™ 4.0 and dichotomized into high-score (76 patients) and low-score groups (71 patients). Univariate and multivariable logistic regression analyses were performed to identify risk factors for low HRQOL, with subgroup analyses stratified by relapse frequency. Results Of 203 pediatric patients screened, 147 were enrolled (79 female, 53.7%); median age at onset was 6.0 (4.0–9.0) years, with a mean follow-up of 44.8 ± 12.4 months. Children with MOGAD had significantly lower HRQOL scores than healthy controls (P < 0.001). Age at onset (OR = 1.238; 95%CI=1.086-1.411; P = 0.001), relapsing course (OR = 4.345; 95%CI =2.017-9.359; P = 0.014), and optic neuritis as the first acute phenotype (OR = 3.895, 95%CI=1.485-10.216; P = 0.046) were independently associated with an increased risk of low HRQOL scores. Further subgroup analysis stratified by relapse frequency revealed that patients experiencing a second attack had a significantly higher risk of low HRQOL than those with other relapse frequencies (OR = 3.794; 95%CI=1.388-8.371; P = 0.009). Cox regression and Kaplan–Meier survival analyses further demonstrated that, compared with the high-HRQOL group, the low-HRQOL group had a significantly shorter time to relapse and a higher relapse rate (HR = 3.46; 95% CI = 1.93–6.18; P < 0.001). Conclusion HRQOL is significantly impaired in children with MOGAD compared with healthy age-matched controls. Age at onset, optic neuritis as the initial phenotype, and disease relapse were independent risk factors for low HRQOL. The second attack was significantly associated with a higher risk of low HRQOL. Targeting the second attack may therefore offer a key window for intensified psychosocial and rehabilitative interventions. Prospective studies are warranted to validate these findings and inform strategies to preserve long-term quality of life in this population.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.2017057
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern

Qing Zhao, Chong Liu, Xin Wang, Kang Liu et al.
7 links
Frontiers in Immunology
Multiple Sclerosis Research Studies
article

Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern

Qing Zhao, Chong Liu, Xin Wang, Kang Liu, Baoguang Li, Ruibin Zhao, Xiaofei Zhang, Huixiao Zheng, Pengqian Zhang, Li Guo, Fang Chen, Yi Qu, Yu Zhang
article en

Abstract

Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is the most common inflammatory demyelinating disease in children, yet few studies have examined health-related quality of life (HRQOL) in this population. This study aimed to compare HRQOL between children with MOGAD and healthy controls, and to identify risk factors for impaired HRQOL. Methods In this retrospective, single-center case-control study, children with MOGAD (147 patients) and healthy controls (150 subjects) were enrolled. HRQOL was assessed using the PedsQL™ 4.0 and dichotomized into high-score (76 patients) and low-score groups (71 patients). Univariate and multivariable logistic regression analyses were performed to identify risk factors for low HRQOL, with subgroup analyses stratified by relapse frequency. Results Of 203 pediatric patients screened, 147 were enrolled (79 female, 53.7%); median age at onset was 6.0 (4.0–9.0) years, with a mean follow-up of 44.8 ± 12.4 months. Children with MOGAD had significantly lower HRQOL scores than healthy controls (P < 0.001). Age at onset (OR = 1.238; 95%CI=1.086-1.411; P = 0.001), relapsing course (OR = 4.345; 95%CI =2.017-9.359; P = 0.014), and optic neuritis as the first acute phenotype (OR = 3.895, 95%CI=1.485-10.216; P = 0.046) were independently associated with an increased risk of low HRQOL scores. Further subgroup analysis stratified by relapse frequency revealed that patients experiencing a second attack had a significantly higher risk of low HRQOL than those with other relapse frequencies (OR = 3.794; 95%CI=1.388-8.371; P = 0.009). Cox regression and Kaplan–Meier survival analyses further demonstrated that, compared with the high-HRQOL group, the low-HRQOL group had a significantly shorter time to relapse and a higher relapse rate (HR = 3.46; 95% CI = 1.93–6.18; P < 0.001). Conclusion HRQOL is significantly impaired in children with MOGAD compared with healthy age-matched controls. Age at onset, optic neuritis as the initial phenotype, and disease relapse were independent risk factors for low HRQOL. The second attack was significantly associated with a higher risk of low HRQOL. Targeting the second attack may therefore offer a key window for intensified psychosocial and rehabilitative interventions. Prospective studies are warranted to validate these findings and inform strategies to preserve long-term quality of life in this population.

Frontiers in ImmunologyVol. 17
Hebei Medical University (CN), Hospital of Hebei Province (CN), Second Hospital of Hebei Medical University (CN)
Good health and well-being
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon